Species: Pseudoleptotrichia sp. HMT-392 (HMT-0392) Primary Body Site: Oral
Download Options
LINKS: Ecology Home
| HMT-0392: [Body Sites Data]
[Taxon Description]
| Life Page: Pseudoleptotrichia sp. HMT-392
Hide Legend
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Body Site Legend:
| SUBP-- Subgingival Plaque |
| SUPP -- Supragingival Plaque |
| PERIO -- Periodontal |
| AKE -- Attached Keratinized Gingiva |
| BMU -- Buccal Mucosa |
| HPA -- Hard Palate |
| SAL -- Saliva |
| THR -- Throat |
| PTO -- Palatine Tonsils |
| TDO -- Tongue Dorsum |
| ANA -- Anterior Nares |
| LRC -- L_Retroauricular Crease |
| RRC -- R_Retroauricular Crease |
| LAF -- L_Antecubital Fossa |
| RAF -- R_Antecubital Fossa |
| VIN -- Vaginal Introitus |
| MVA -- Mid Vagina |
| PFO -- Posterior Fornix |
| STO -- Stool |
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Human Microbiome Project Mapping (Data from healthy subjects. - not published)
No Notes
Eren V1-V3 www.pnas.org
(Data from healthy subjects.)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.29 | 0.44 | 0.01 | 0.03 | 0.01 | 0.05 | 0.01 | 0.01 | 0.01 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 1.02 | 1.23 | 0.02 | 0.07 | 0.02 | 0.09 | 0.04 | 0.03 | 0 | 0 |
| Stdev | 0.71 | 1.26 | 0.08 | 0.10 | 0.02 | 0.20 | 0.03 | 0.03 | 0.04 | 0.01 |
| Prev(%) | 53.25 | 50.65 | 12.99 | 31.17 | 18.18 | 29.87 | 11.69 | 20.78 | 7.79 | 1.30 |
Eren V3-V5 www.pnas.org
(Data from healthy subjects.)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.30 | 0.36 | 0.01 | 0.04 | 0.01 | 0.05 | 0.01 | 0.03 | 0.01 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.69 | 1.00 | 0.02 | 0.14 | 0.04 | 0.12 | 0.04 | 0.06 | 0.03 | 0 |
| Stdev | 0.67 | 0.64 | 0.03 | 0.10 | 0.04 | 0.10 | 0.04 | 0.08 | 0.02 | 0 |
| Prev(%) | 62.84 | 69.59 | 12.84 | 35.13 | 25.00 | 41.89 | 22.97 | 29.05 | 22.30 | 0 |
Human Microbiome Project 16S RefSeq (V1-V3) (Data from healthy subjects. - not published)
Notes:
Because HMT-217 is not present individually, all equidistant reads were assigned to HMT-392 at these sites (SAL,SUPP).
Because HMT-217 is not present individually, all equidistant reads were assigned to HMT-392 at these sites (SAL,SUPP).
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.39 | 0.51 | 0.04 | 0.06 | 0.02 | 0.10 | 0.03 | 0.03 | 0 | 0 | 0.01 | 0 | 0.02 | 0.02 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 1.07 | 1.58 | 0.04 | 0.15 | 0.05 | 0.21 | 0.06 | 0.06 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0.77 | 0.96 | 0.22 | 0.15 | 0.06 | 0.29 | 0.10 | 0.12 | 0 | 0 | 0.17 | 0.04 | 0.18 | 0.12 | 0 | 0 | 0 | 0 |
| Prev(%) | 66.89 | 72.85 | 25.18 | 55.48 | 28.19 | 43.85 | 26.79 | 40.00 | 0 | 0 | 4.31 | 3.68 | 4.02 | 5.53 | 0 | 0 | 0 | 0 |
Human Microbiome Project 16S RefSeq (V3-V5) (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.43 | 0.52 | 0 | 0.12 | 0 | 0.09 | 0.05 | 0.07 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 1.21 | 1.66 | 0 | 0.29 | 0 | 0.24 | 0.08 | 0.12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0.76 | 0.89 | 0 | 0.34 | 0 | 0.17 | 0.17 | 0.21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Prev(%) | 75.56 | 75.37 | 0 | 46.90 | 0 | 54.76 | 30.53 | 44.28 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dewhirst 35x9 (35 Taxa by 9 Oral Sites. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | |
| Avg (%) | 0.49 | 0.42 | 0.07 | 0.10 | 0.35 | 0.02 | 0.09 | 0.03 | 0.03 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 1.47 | 1.08 | 0.08 | 0.20 | 0.11 | 0.06 | 0.07 | 0.03 | 0.03 | 0 |
| Stdev | 1.31 | 0.50 | 0.26 | 0.25 | 1.62 | 0.04 | 0.33 | 0.13 | 0.09 | 0 |
| Prev(%) | 79.73 | 85.29 | 72.09 | 74.29 | 71.43 | 72.00 | 69.70 | 51.61 | 50.00 | 0 |
Human Microbiome Project Metaphlan (Data from healthy subjects. - not published)
No Notes
